Debt-to-equity in % of NKGen Biotech, Inc. from Q1 2022 to Q4 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: NKGen Biotech, Inc. quarterly Debt-to-equity history and change rate from Q1 2022 to Q4 2024.
NKGen Biotech, Inc. Debt-to-equity for the quarter ending 31 Dec 2024 was -126 %, a 5.64% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

NKGen Biotech, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q4 2024	-126	+7.54	+5.64%	31 Dec 2024
Q3 2024	-128	+41.5	+24.6%	30 Sep 2024
Q2 2024	-133	-84.2	-173%	30 Jun 2024
Q1 2024	-133	-104	-356%	31 Mar 2024
Q4 2023	-134	-101	-312%	31 Dec 2023
Q3 2023	-169	-146	-624%	30 Sep 2023
Q2 2023	-48.7	-8.53	-21.2%	30 Jun 2023
Q1 2023	-29.2	+47.6	+62%	31 Mar 2023
Q4 2022	-32.4			31 Dec 2022
Q3 2022	-23.4			30 Sep 2022
Q2 2022	-40.2			30 Jun 2022
Q1 2022	-76.8			31 Mar 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.